(Sharecast News) - Niox Group reported strong first-half trading on Tuesday, driven by robust growth in both clinical and research revenues, and said it remained confident in its strategic plans despite some uncertainty around research demand.
Revenue for the six months ended 30 June rose 20% year-on-year to about £25.2m, or...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE